Page last updated: 2024-10-27

furazolidone and Respiratory Tract Diseases

furazolidone has been researched along with Respiratory Tract Diseases in 2 studies

Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.

Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
COSGROVE, AS1
van Cauwenberge, H1

Other Studies

2 other studies available for furazolidone and Respiratory Tract Diseases

ArticleYear
Inhalation treatment of chronic respiratory disease in chickens: controlled field studies with furazolidone and dihydrostreptomycin dusts.
    Journal of the American Veterinary Medical Association, 1958, Nov-15, Volume: 133, Issue:10

    Topics: Animals; Chickens; Chronic Disease; Dihydrostreptomycin Sulfate; Disease; Dust; Furans; Furazolidone

1958
[Current therapeutics in clinical medicine].
    Revue medicale de Liege, 1969, Jun-01, Volume: 24, Issue:11

    Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Cephalosporins; Endocrine Sys

1969